IGF1 and benign prostatic hyperplasia: This is reinforced by the fact that insulin-like growth factor (IGF) is known to exist in prostatic tissue, and any pathologic anomalies in the IGF system are noted to be present among the prostatic stroma cells in BPH patients [47,48].